Healthcare News and Research

Latest Healthcare News and Research

Bayer announces FDA acceptance of BAY 81-8973 BLA for treatment of hemophilia A

Bayer HealthCare today announced that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for BAY 81-8973, a recombinant Factor VIII compound. Bayer is seeking FDA approval of the investigational compound, proposed trade name Kovaltry, for the treatment of hemophilia A in children and adults.

4 Mar 2015

Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.

4 Mar 2015

IMRIS announces net loss of $6.8 million for fourth quarter 2014

IMRIS Inc. today reported financial results for the fourth quarter and full year ended December 31, 2014. All figures are reported in U.S. dollars. The Company's net loss in the 2014 fourth quarter was $6.8 million, or $0.13 per diluted share, on net revenues of $9.6 million.

4 Mar 2015

Resverlogix, Emerald Logic complete collaborative research program

Resverlogix Corp. today announced that it has completed a collaborative research program with Emerald Logic, a leader in quantitative analytics. Using Fast Collective Evolution Technology (FACET), Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Company's Phase 2 clinical trials ASSERT, SUSTAIN and ASSURE.

4 Mar 2015

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes.

4 Mar 2015

New CPPP report shows that one in four Texas children lives in poverty

One in four Texas children lives in poverty, threatening their potential and the state's continued prosperity. According to State of Texas Children 2015, a new Center for Public Policy Priorities (CPPP) report released today, slight improvements in health care and school nutrition don't compensate for inadequate investments in education and child protection.

4 Mar 2015

Reducing premature deaths from noncommunicable diseases: an interview with Dr Shanthi Mendis, WHO

The main types of NCD are cardiovascular disease, cancer, chronic respiratory diseases and diabetes. These have been identified as the principal conditions for three main reasons. One is that, collectively, they contribute the most to the total disease burden.

4 Mar 2015

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Halyard Health, Inc. today reported year-end 2014 results and provided its 2015 outlook and related key planning assumptions.

4 Mar 2015

CHOP earns Level 2 ACO accreditation

The National Committee for Quality Assurance has announced that The Children's Hospital of Philadelphia has earned accreditation as a Level 2 Accountable Care Organization.

4 Mar 2015

New book highlights practical strategies for delivering STEEEP health care

Achieving health care that is safe, timely, effective, efficient, equitable, and patient-centered care (STEEEP) is not an endpoint, but a journey. This journey requires a commitment to quality improvement from the highest levels of leadership combined with the interdependent development of several key components of health care delivery: administration and governance, clinical leadership, quality programs and expertise, data analytics, and accreditation.

4 Mar 2015

CCO wants men and women in Ontario to get screened for colorectal cancer

March is Colorectal Cancer Awareness Month, and Cancer Care Ontario wants men and women to start thinking about getting screened.

4 Mar 2015

Novogen's TRXE-009 therapy shows promise against brain cancer

Australian/US biotechnology company, Novogen Limited, today announces that it has confirmed that one of its lead candidate products, TRXE-009, is showing the potential to become an important new therapy in the fight against adult and pediatric brain cancer.

4 Mar 2015

New healthcare law may threaten federally subsidized coverage for over 2.5 million Americans

A new study shows that over 2.5 million Americans who have a serious mental health condition in 34 states will become uninsured in 2016, if the Supreme Court rolls back tax credit subsidies that currently make it affordable for those individuals to purchase coverage on federally-run health insurance marketplaces under the Affordable Care Act.

4 Mar 2015

Grifols, Alkahest sign definitive agreements

Grifols, a global healthcare company and leading producer of plasma therapies, and Alkahest, a Redwood City, California based, privately held biopharmaceutical company founded upon the pioneering work of Dr. Tony Wyss-Coray and other leading scientists at Stanford University, today announced that they have signed definitive agreements whereby Grifols will make a major equity investment in Alkahest, and the companies will work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system (CNS), including Alzheimer's.

4 Mar 2015

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

SARAH, a large French study of patients with advanced, inoperable primary liver cancer (hepatocellular carcinoma, or HCC) has completed patient enrolment, exceeding its 400-patient target, according to its principal investigator, Professor Valérie Vilgrain MD, PhD, Department of Radiology, Beaujon Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP) and Université Paris Diderot, Sorbonne Paris Cité, France.

4 Mar 2015

New study shows who benefits most from statin therapy

Research has demonstrated that the risk for developing coronary heart disease depends on a host of risk factors that are related both to lifestyle and genetics. In a new study from Brigham and Women's Hospital, Washington University School of Medicine in St. Louis, and Massachusetts General Hospital, researchers tested whether a composite of genetic variants could identify the risk of cardiovascular death and heart attacks as well as identify individuals who derived greater clinical benefit from statin therapy.

4 Mar 2015

USciences recognizes Adeboye Adejare with 2015 Founders' Day Faculty Award of Merit

University of the Sciences proudly recognized pharmaceutical sciences professor Adeboye Adejare, PhD, with the 2015 Founders' Day Faculty Award of Merit during the University's 194th Founders' Day Ceremony on Thursday, Feb. 19.

4 Mar 2015

Non-drug approaches work better in people with Alzheimer's disease, dementia

Doctors write millions of prescriptions a year for drugs to calm the behavior of people with Alzheimer's disease and other types of dementia. But non-drug approaches actually work better, and carry far fewer risks, experts conclude in a new report.

4 Mar 2015

OTC medications, dietary and herbal supplements cause drug-induced acute liver failure

Drug-induced acute liver failure is uncommon, and over-the-counter medications and dietary and herbal supplements -- not prescription drugs -- are its most common causes, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

4 Mar 2015

New antibody provides 100% protection against H5N1 influenza virus in animal models

Since 2003, the H5N1 influenza virus, more commonly known as the bird flu, has been responsible for the deaths of millions of chickens and ducks and has infected more than 650 people, leading to a 60 percent mortality rate for the latter. Luckily, this virus has yet to achieve human-to-human transmission, but a small number of mutations could change that, resulting in a pandemic.

4 Mar 2015

Healthcare News and Research

Latest Healthcare News and Research

Bayer announces FDA acceptance of BAY 81-8973 BLA for treatment of hemophilia A

Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

IMRIS announces net loss of $6.8 million for fourth quarter 2014

Resverlogix, Emerald Logic complete collaborative research program

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

New CPPP report shows that one in four Texas children lives in poverty

Reducing premature deaths from noncommunicable diseases: an interview with Dr Shanthi Mendis, WHO

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

CHOP earns Level 2 ACO accreditation

New book highlights practical strategies for delivering STEEEP health care

CCO wants men and women in Ontario to get screened for colorectal cancer

Novogen's TRXE-009 therapy shows promise against brain cancer

New healthcare law may threaten federally subsidized coverage for over 2.5 million Americans

Grifols, Alkahest sign definitive agreements

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

New study shows who benefits most from statin therapy

USciences recognizes Adeboye Adejare with 2015 Founders' Day Faculty Award of Merit

Non-drug approaches work better in people with Alzheimer's disease, dementia

OTC medications, dietary and herbal supplements cause drug-induced acute liver failure

New antibody provides 100% protection against H5N1 influenza virus in animal models

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in